MM

Manishi Mehru

Director Director DIN 07098790
DIN 07098790 First appointment Apr 2015 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Manishi Mehru

Data last updated:

Manishi Mehru was a Director at Dorret Pharma Private Limited (2015–2016) and Director at Atri Logistics Private Limited (2016). The companies operate in Chemicals and Business Services.

DIN 07098790
Primary Designation Director
Industry Chemicals
First Appointment 10 Apr 2015

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dorret Pharma Private Limited U24232RJ2015PTC047344
Director10 Apr 20152015Strike Off
Atri Logistics Private Limited U74999RJ2016PTC055061
Director26 May 20162016Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dorret Pharma Private Limited
Atri Logistics Private Limited
Premium access

Shareholding and investment profile for Manishi Mehru

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manishi Mehru

Manishi Mehru was first appointed on 10 Apr 2015 as Director at Dorret Pharma Private Limited. The most recent appointment on record is 26 May 2016 at Atri Logistics Private Limited.

Manishi Mehru held 2 earlier board appointments: Dorret Pharma Private Limited (Director, 10 Apr 2015 to 28 May 2016); Atri Logistics Private Limited (Director, 26 May 2016 to 28 May 2016).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available